Several New GLP-1 Agonists Added to the Web Page. All Are Potentially Cancer-provoking.

Page Changed: GLP-1 Agonists: Byetta, Lyxumia, Bydureon, Victoza, Trulicity and Tanzeum Text Added:

Byetta, Lyxumia, Bydureon, Victoza, Trulicity and Tanzeum

These drugs are all members of the incretin drug family. Byetta (exenatide) is injected several times a day, Victoza (liraglutide) and Lyxumia (lixisenatide) once a day. Saxenda is the same drug as Victoza, but it has been approved for people without diabetes who need to achieve weight loss. Bydureon is a long lasting version of exenatide. It, Trulicity, (dulaglutide) and Tanzeum (albiglutide) are injected once and last a full week.